With the IBB performing poorly and increased confusion in the biotech market, is it time for investors to be bullish?
Find out how House Majority Leader Kevin McCarthy has voted in the past.
One famed analyst says this might be the perfect time for commodities investors to pounce.
Ivy League rivals, Yale and Harvard, beat the S&P 500's performance in fiscal 2015.
One analyst says an automaker that competes with Volkswagen may have the right product formula to benefit now.
The iShares Nasdaq Biotechnology ETF took a visible leg down after the 10:56 a.m. ET tweet by the presidential candidate.
Millennials do the most online shopping but Gen Xers spend the most money, creating a dual challenge for advertisers.
Despite stock being down 37 percent year-to-date, Mark Mahaney still thinks Alibaba is "a fundamentally good asset."
Yale University professor and CNBC contribuor Jeff Sonnenfeld weighs in on GOP Debate mention and Carly Fiorina's record.
The tech giant introduced new upgrades on its Fire product line, complete with a new operating system, 'Bellini.'